| Title : Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers - Yang_2017_Chest_151_555 |
| Author(s) : Yang L , Cheriyan J , Gutterman DD , Mayer RJ , Ament Z , Griffin JL , Lazaar AL , Newby DE , Tal-Singer R , Wilkinson IB |
| Ref : Chest , 151 :555 , 2017 |
| Abstract : Yang_2017_Chest_151_555 |
| ESTHER : Yang_2017_Chest_151_555 |
| PubMedSearch : Yang_2017_Chest_151_555 |
| PubMedID: 27884766 |
| Title : Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor - Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| Author(s) : Lazaar AL , Yang L , Boardley RL , Goyal NS , Robertson J , Baldwin SJ , Newby DE , Wilkinson IB , Tal-Singer R , Mayer RJ , Cheriyan J |
| Ref : British Journal of Clinical Pharmacology , 81 :971 , 2016 |
| Abstract : Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| ESTHER : Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| PubMedSearch : Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| PubMedID: 26620151 |
| Title : In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor - Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25 |
| Author(s) : Podolin PL , Bolognese BJ , Foley JF , Long E, 3rd , Peck B , Umbrecht S , Zhang X , Zhu P , Schwartz B , Xie W , Quinn C , Qi H , Sweitzer S , Chen S , Galop M , Ding Y , Belyanskaya SL , Israel DI , Morgan BA , Behm DJ , Marino JP, Jr. , Kurali E , Barnette MS , Mayer RJ , Booth-Genthe CL , Callahan JF |
| Ref : Prostaglandins Other Lipid Mediat , 104-105 :25 , 2013 |
| Abstract : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25 |
| ESTHER : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25 |
| PubMedSearch : Podolin_2013_Prostaglandins.Other.Lipid.Mediat_104-105_25 |
| PubMedID: 23434473 |